Kewaunee Scientific (NASDAQ:KEQU) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen upgraded shares of Kewaunee Scientific (NASDAQ:KEQU) from a hold rating to a buy rating in a report published on Saturday morning.

Kewaunee Scientific Trading Up 2.4%

Shares of NASDAQ KEQU opened at $58.94 on Friday. The company’s fifty day moving average is $39.60 and its 200-day moving average is $47.66. The stock has a market cap of $167.39 million, a price-to-earnings ratio of 15.39 and a beta of 0.70. Kewaunee Scientific has a twelve month low of $30.33 and a twelve month high of $71.33. The company has a quick ratio of 1.54, a current ratio of 2.20 and a debt-to-equity ratio of 0.92.

Kewaunee Scientific (NASDAQ:KEQU) last announced its quarterly earnings results on Wednesday, June 25th. The technology company reported $1.95 earnings per share for the quarter. Kewaunee Scientific had a net margin of 4.74% and a return on equity of 26.02%. The company had revenue of $77.15 million for the quarter.

Insiders Place Their Bets

In related news, CFO Donald T. Gardner III sold 3,000 shares of the firm’s stock in a transaction on Wednesday, April 9th. The shares were sold at an average price of $37.75, for a total transaction of $113,250.00. Following the sale, the chief financial officer directly owned 15,358 shares in the company, valued at $579,764.50. This trade represents a 16.34% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Thomas David Hull III sold 1,844 shares of the firm’s stock in a transaction on Monday, April 14th. The stock was sold at an average price of $32.44, for a total transaction of $59,819.36. Following the sale, the chief executive officer owned 36,072 shares in the company, valued at approximately $1,170,175.68. The trade was a 4.86% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 14.20% of the company’s stock.

Institutional Investors Weigh In On Kewaunee Scientific

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Jane Street Group LLC acquired a new stake in shares of Kewaunee Scientific during the fourth quarter worth $300,000. Truffle Hound Capital LLC acquired a new stake in Kewaunee Scientific in the 4th quarter valued at $619,000. Marshall Wace LLP acquired a new stake in Kewaunee Scientific in the 4th quarter valued at $736,000. American Century Companies Inc. increased its stake in Kewaunee Scientific by 18.0% in the 4th quarter. American Century Companies Inc. now owns 34,293 shares of the technology company’s stock valued at $2,122,000 after buying an additional 5,221 shares during the last quarter. Finally, O Shaughnessy Asset Management LLC increased its stake in Kewaunee Scientific by 3.3% in the 4th quarter. O Shaughnessy Asset Management LLC now owns 28,008 shares of the technology company’s stock valued at $1,733,000 after buying an additional 891 shares during the last quarter. 32.69% of the stock is currently owned by institutional investors and hedge funds.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.